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Arthropod-borne viruses (arboviruses) are viruses transmitted by arthro
pod vectors between vertebrate hosts. Three elements are thought to charac
terize the interrelationship of virus, host, and vector. The virus multiplies
in the tissues of both host and vector, sometimes yielding disease or overt
evidence of infection in the former but no detectable effects in the latter.
An extrinsic incubation period occurs between ingestion and transmission of
the virus by the vector. Presumably the virus also exists at any given time
in either arthropod or vertebrate (1).
To be characterized as an arbovirus a virus should ideally be demonstrated
to fit the above definition in an orderly, complete fashion. Practically, such
demonstrations are generally impossible at this time. Consequently, arbovirus
characterization is based on more indirect evidence.
Physical parameters are helpful to a limited extent. Most arboviruses thus
far are found to be 20-100 mu in diameter, to be sensitive to diethyl ether
or sodium deoxycholate, and to contain RNA (11). Effects of the viruses in
vivo are likewise helpful, such as their pathogenicity for laboratory animals,
especially the baby mouse, the lesions thev produce in tissue cultures, and
proof of their asymptomatic multiplication in possible arthropod vectors.
However, even more important as indirect evidence for viruses being arbo
viruses are the circumstances under which they were isolated originally. Such
evidence is present, for example, when viruses are found in materials gathered
from large collections of arthropods, both wild and domestic animal populations,
sentinel animals, and individual animals and humans that are appropriately ill.
Similarly important to this indirect characterization of a virus as an
arbovirus is the serological relationship of a proposed arbovirus to a
known one .
Classification of the arboviruses systematically is based primarily on
their serological interrelationships, which are stable (9), easily determined,
and fairly well understood common properties. On the basis of serological simi
larities, apparently reflecting sharing of common antigenic structures, most
of the 252 arboviruses thus far sufficiently studied have been arranged into
twenty-eight groups and one supergroup. Fifty-six, however, are as yet ungrouped
(24). Within these groups serological differences among members, thought to
reflect differences in antigenic structures, establish the varying degrees of
individuality of the viruses.
Serologic means used in characterization and classification of arboviruses
include the hemagglutination-inhibition (HI), complement-fixation (CF) , and
neutralization (NT) techniques. Several degrees of simplicity, rapidity, and
inclusiveness exist among these tests, and numerous variations and extensions
may be introduced into them as suits the end desired (e.g., more inclusive
tests are usually required for grouping, more exclusive for typing) (2). Other
techniques are occasionally employed in arbovirus classification, including
agar gel immuno-electrophoresis and cross-challenge. These, however, are pre
sently in the stage of development, or of limited applicability, and not in
common use.
Importances of the arboviruses are manifold, including both practical
aspects, since they are disease agents with medical and economic consequences
in man and animals, and academic aspects, as well. Either alone would be
sufficient to justify their study.
The Yale Arbovirus Research Unit (YARU), formerly the Rockefeller Foundation
Virus Laboratories, is a multi-purpose organization contributing both to the
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study of various aspects of arboviruses, in conjunction with other organizations
throughout the world, and to the teaching of students of medicine and public
health (14, 25). The research dealt with in this paper was undertaken within
the teaching program at YARU and as part of its study of arbovirus serology and
immunology, here mainly in association with the Arbovirus Research Project of the
University of Ibadan in Nigeria.
In its study of the arbovirus ecology of Nigeria, the University of
Ibadan Project has collected several arbovirus isolates, including seven of
the eight subjects of this paper. The eighth was also isolated in Nigeria
by Dr. C.C. Draper and his colleagues of the West African Council for Medical
Research, and then studied in part by the East African Virus Research Institute.
All of the isolates belong to group Simbu, and their collection, characterization,
and preliminary classification were carried out using the various means previously
alluded to, in whole or in part. Table 1 contains basic descriptive and reference
information relevant to these isolates and their study here. This includes virus
numerical designation and provisional name, and virus passage levels employed,
as well as date, location, and source of the virus isolation, the isolating
organization, and literature reference to the isolation.
The Simbu group of arboviruses belongs in the Bunyamwera supergroup, which
also includes groups Bunyamwera, Bwamba, C, California, Capim, Koongol, and
Guama, and several unassigned viruses (4, 24). Other members of group Simbu,
in addition to the isolates studied here, include Akabane, Buttonwillow, Ing-
wavuma (SA An 4165), Manzanilla, Oropouche, Sathuperi (IG 10310), Simbu, and
Utinga (Be An 84785) (24). Simbu virus originally described by Weinbren, et al.,
is the group prototype (20, 23)- Serological experience with the group has
shown that its members often lack easily prepared hemagglutinating activity, and
that of the three common serological tests (HI, CF, and NT) CF is the most
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inclusive in the relationships it demonstrates, HI and NT being considerably
more exclusive. Medical and consequent economic importance of the group is still
incompletely studied. Presently it appears that member viruses do not cause
dangerous, permanently damaging, or fatal diseases in man. However, Oropouche
virus is known to cause a very unpleasant, febrile illness in man, which may be
of epidemic proportions, and consequently quite serious economically (21). Further
more, lb H 11003, one of the isolates studied here, was isolated from a febrile
human child, although nothing more of its medical importance is yet known. The
possible role of group Simbu viruses in diseases of livestock, where some of
them appear ubiquitously, is also yet to be studied.








Source Location Date Organization* Reference
Yaba 7
lb An 5077 Sango
af ricana)
market cattle blood
lb An 5550 Shamonda 2,3,4 market cattle blood
lb An 9398 Sabo 2,6,7 Goat blood
lb An 10107 Shuni 1,2,3 Cattle blood
lb An 10598 3,4,5 Cattle blood
lb An 10599 2,3,4 Cattle blood
lb H 11003 _ _ _ 3,4 febrile human femaL
1 and 1/2 years old,
heparinized blood
Yaba, Lagos, Nigeria 3/63 1 (18)
Dugbe slaughterhouse, 4/26/65 2 (7)
Ibadan, Nigeria
Ibadan, Nigeria 5/20/65 2 (7)
slaughterhouse , 4/18/66 2 (8)
Ibadan, Nigeria
slaughterhouse, 5/12/66 2 (8)
Sokoto, Nigeria
Ibadan, Nigeria 6/27/66 2 (8)
Ibadan, Nigeria 6/27/66 2 (8)




* 1: West African Council for Medical Research
2: University of Ibadan, Arbovirus Research Project
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THE PROBLEM
The experiments hereafter described were intended to deal with two problems,
essentially, one more academic, the other more practical.
The more academic efforts were meant to establish the serological distinc
tions and relationships among the eight group Simbu isolates previously men
tioned. Techniques employed were CF, HI, and NT, using hyperimmune mouse
ascitic fluid and antigens produced originally for these experiments, where
possible. Such creation of an inter-isolate serological classification was
intended to enhance and verify basic knowledge regarding these viruses.
The more practical attempts were those made to prepare hemagglutinating
antigens for all eight isolates. The intention in this case was to enable
performance of the rapid, simple HI test, useful for virus and antibody
identification both diagnostically and in serological surveys.
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MATERIALS AND METHODS
Virus, Antigen, and Antibody
Lyophilized virus isolates stored in the WHO reference bank at YARU were
used to produce isolate-specif ic complement-fixing and hemagglutinating antigen
and hyperimmune mouse ascitic fluids.
Antigens were prepared in essentially the manner described bv Clarke
and Casals in 1958 (10). Lyophilized virus (of passage level indicated in
Table 1) was reconstituted with phosphate buffered bovine albumin (BAP),
prepared to 0.75% concentration, pH approximately 7.2, by addition of phosphate
buffered saline (PBS) to commercial 7.5% BAP on hand. Final virus concentra
tion was 1% in BAP. Using a 26-gauge needle and glass syringe, 0.015 cc of this
reconstituted virus was inoculated intracerebrally into seventy, one- to two-
day old, suckling mice. These mice were observed daily until some were dead
and the others moribund with signs of encephalitis (paralysis, convulsions;
usually within one to three days post-inoculation) . The moribund were then
collected and frozen in polyethylene bags at -70C until sucrose-acetone
extraction of brain took place.
After thawing the frozen mice and removing their brains, using either a
13-gauge needle on a vacuum line with a bottle trap, or an 18-gauge needle
and a 1 cc tuberculin syringe, sucrose-acetone extraction began. The total
weight of the brains removed was determined on a triple-beam balance and
a 20% suspension (by weight) made of them in 8.5% aqueous sucrose solution.
This suspension was homogenized for one minute in a Lourdes blender. The
homogenate thus prepared was then rapidly expressed from a 50 cc syringe through
an 18-gauge needle into twenty volumes of cold acetone in a reagent bottle,
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the mixture shaken vigorously and thoroughly, and the supernate decanted.
Twenty more volumes of cold acetone were immediately added to the precipitate
in aliquots of three to four volumes, with vigorous shaking between each
aliquot. The precipitate was allowed to settle from this supernate for one
hour at 4C. The supernate was then carefully decanted and the precipitate
vacuum-dried for one hour. Finally the dried precipitate, still in the
reagent bottle, was rehydrated overnight at 4C with a volume of normal saline
equal to twice the total weight of extracted brains.
This sucrose-acetone extracted antigen was stored at 4C from a few
hours to several days before undergoing hemagglutination titration. There
after it was either kept frozen at -70C or lyophilized in ampoules of 0.5 cc
amounts, after centrifugation for 10 minutes at 10,000 rpm.
Hemagglutination titration was accomplished using a microtechnique
similar to that described by Sever (16). Special eauipment involved included
reusable lucite plates containing ninety-six 6x6x10 mm wells in an 8x12 well
pattern, pipettes calibrated to deliver reagents in 0.025 cc drops, and
diluting loops calibrated to deliver 0M25 cc from well to well. Reagents
other than antigen included bovine albumin diluent, and a suspension of goose
erythrocytes in virus adjusting diluent (VAD). Bovine albumin diluent
consisted of a pH 9.0, 0.4% solution of commercial bovine albumin in borate
saline. The goose erythrocyte suspension was composed of goose erythrocytes
suspended in phosphate buffered saline (VAD) of the pH required bv the test.
The suspension had an optical density of 0.75 atA=490.
After centrifugation at 2000 rpm for ten minutes, each antigen was titrated
at five different pH levels (5.8, 6.0, 6.2, 6.4, 6.6), in eight, serial,
two-fold dilutions from 1:2 to 1:256. One row of eight wells was used for
each pH. To each of the second through eighth wells, one drop of bovine albumin
diluent was added, and to both the first and second wells, one drop of antigen.
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The excess fluid in the second well was then transferred progressively through
the succeeding wells, with thorough mixing in each, finally to be discarded
after the eighth well. Thus the serial two-fold dilutions were arranged. One
drop of bovine albumin diluent and two drops of goose erythrocyte suspension
of the proper pH were then added to each of the eight wells, and thorough
mixing insured in all wells hv gentle tapping of the plate corners.
After a thirty to forty-five minute incubation at room temperature, all
wells were scanned for the endpoint indicating the pH level developing the
highest titer hemagglutinating activity. This endpoint was defined as the
greatest dilution of antigen showing complete or partial hemagglutination.
Hyperimmune mouse ascitic fluids specific for each isolate were prepared.
Such fluid as prepared here has been shown elsewhere (15,22) to possess antibody
of equally as high titer and specificity as sera from the same animals. It is
consequently considered hereafter as the equivalent of such sera.
The fluids used in this research, with one exception, were prepared as
follows, sterile technique being observed to the point of inoculation of the
adult mice. A virus-containing brain was removed by autopsy from the carcass
of a frozen suckling mouse infected as previously described for antigen
production. A 10% saline suspension of this infected brain was then made
with mortar and pestle. The suspension was emulsified with Freund's complete
adjuvant using a syringe, and 0.2 cc of this emulsion was then inoculated intra-
peritoneally into six week old (adult) male mice. This procedure was repeated
seven and fourteen davs later using the same adult male mice. At day fifteen
they received intraperitoneally 0.2 cc of a 10% saline suspension of Sarcoma
180/TG ascitic fluid, Sarcoma 180/TG being a slow-growing tumor producing
large amounts of ascitic fluid. At dav twenty-one thev once more received the
infected brain emulsion.
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Generally by day twenty-eight, two weeks after the sarcoma injection,
ascites had developed. Paracentesis was then performed on each mouse, with
removal of as much hyperimmune ascitic fluid as possible. Such paracentesis
was repeated as fluid reaccumulated, until death of the mice. The ascitic fluid
collected was centrifuged at 10,000 rpm for five minutes, the pellet discarded,
and the supernatant fluid stored at -20C until use.
Immune status of the ascitic fluids thus produced was determined by
homologous CF testing in all cases and by homologous NT and HI tests as
further warranted. Those fluids yielding a homologous titer of at least
1:32 by CF, and 1:10 by HI (as far as determinable), and a log., neutralization
index of greater than 1.6 by NT were used In further heterologous experiments.
There was fluid specific for one isolate which did not meet these requirements,
that for lb An 9398. Consequently ascitic fluid hyperimmune to this isolate
was withdrawn from the WHO Reference Laboratory stocks for further use here.
Although it was prepared in a manner similar to that described above, the
schedule followed was different, making it the previously mentioned exception
to this description.
Serological Tests
Complement-fixation testing as modified from the method of Casals (3) was
used. Prior to each actual test, a titration of complement (C1) was routinely
performed. Commercial lyophilized guinea pig serum (C1) rehydrated with its
accompanying diluent was diluted 1:45 using pH 7.4 veronal buffer diluent,
the basic diluent of the CF test. A suspension of sensitized sheep cells
(SSC) was also prepared by diluting a commercial sheep erythrocyte suspension
to 4% in veronal diluent, mixing this suspension with an equal volume of 1:800
hemolysin in veronal diluent solution, and incubating for fifteen minutes in
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a 37C water bath.
The 1:45 C' was serially diluted with veronal diluent to concentrations
between 5% and 40% in nine 100x13 mm test tubes. A 0.2 ml aliquot of each
dilution was mixed with 0.1 ml aliquots of veronal diluent and SSC in separate
test tubes and these incubated, after shaking, for fifteen minutes in a 37C
water bath. They were then reshaken, incubated another fifteen minutes, settled
for one hour at 4C and the results read. The tube containing the least comple
ment (most dilute solution) and still showing complete hemolysis was defined
as containing one unit of C
'
. Since two units of C'/0.1 ml C solution were
requisite for the actual CF test, appropriate adjustment of the 1:45 C could
be made with the veronal diluent, although in actual practice this was never
necessary.
A microtiter technique conservative of reagents was used in the actual
CF tests, employing disposable plastic plates similar to the lucite plates
described in the HA test, and the same reagent droppers as noted there.
After thawing or reconstitution of antigens and ascitic fluids, these were
appropriately diluted, usually in serial, two-fold fashion, with veronal
diluent. The ascitic fluids were incubated twenty minutes in a 60C water bath
while in a 1:4 dilution, their final dilutions being prepared thereafter. To
each plate well one drop of the appropriate ascitic fluid was added, then one
drop of the C' solution, and one drop of the appropriate antigen. Simultaneous
C', uninfected suckling mouse brain antigen, specific ascitic fluid, and specific
antigen controls were also included, as well as a repeat, micro-method C1 titra
tion. The plates were covered and stored overnight at 4CC.
The following morning the plates were warmed for fifteen minutes in a 40C
oven and one drop of freshly prepared SSC added to each well, one plate at a time.
Each plate was gentlv shaken, and incubated thirty minutes in the 40C oven, being
reshaken every ten minutes. Finally the plates were recovered and the well mixtures
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allowed to settle for several hours at 4C. Reading of the results was then made
on a 0 (complete hemolysis) to 4+ (no hemolysis) scale. The endpoint was defined
as the last well (most dilute, in terms of ascitic fluid) having a 3+ to 4+
reading. This was recorded as the reciprocal of the ascitic fluid dilution.
Hemagglutination-inhibition testing modified from that described by Clarke
and Casals (10) and using a microtechnique similar to that of Sever (16) as
previously described for hemagglutination testing, was carried out in a constant
antigen, varying antibody system. Only antigen showing at least four units of
hemagglutination at a 1:4 dilution (at least one HA unit at 1:16) was included.
Ascitic fluid as used in both CF and NT testing was also employed here, after
acetone extraction carried out as follows.
Thawed ascitic fluid was diluted 1:10 in a 2% aqueous solution of commercial
bovine albumin. This was rapidly expressed from a syringe with small bore needle
into twelve volumes of chilled acetone, and the suspension immediately shaken
thoroughly. After swift centrifugation to 2,000 rpm, the supernate was discarded
and twelve more volumes of cold acetone added to the precipitate, followed
again by immediate, thorough shaking. This suspension, after standing five
minutes in an ice bath, was centrifuged swiftly to 10,000 rpm, the supernate
discarded, and the precipitate dried in a vacuum for one hour. The dried
precipitate was then rehydrated overnight at 4C with volume of borate saline
buffer, pH 9.0, equal to that of the original 1:10 dilution of ascitic fluid in
bovine albumin. Acetone extracted ascitic fluid not immediately used was stored
in 1 ml aliquots at -70C and thawed only once before use and/or discarding.
A second technique of acetone extracting ascitic fluid was also attempted,
but was found to be unsatisfactory and discontinued, never being used in the
experiments reported here. It differed from that described above onlv in
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preparation of the 1:10 dilution of ascitic fluid, which was made with saline,
not bovine albumin solution.
For HI tests, ascitic fluid was diluted from 1:10 to 1:320 in serial,
two-fold steps, with 0.4% bovine albumin in borate saline diluent, pH 9.0
(previously described). Antigen, on the basis of previous HA titrations
repeated immediately prior to HI testing, was diluted with the same diluent
to contain 4 HA units.
One drop of the appropriate ascitic fluid in appropriate dilution was
then added to each well in the test, followed by one drop of the antigen.
The plates were incubated overnight at room temperature.
The following morning two drops of goose erythrocytes in VAD suspension
of the optimum pH (determined in the previous HA titrations) were added to
each well, the mixtures shaken by tapping the plate corners gently, and reading
made of the results after further incubation for thirty to forty-five minutes
at room temperature. The endpoint taken was that well containing the most
dilute ascitic fluid which showed no hemagglutination (i.e., complete hemagglu
tination inhibition), and its dilution of ascitic fluid was subsequently recorded.
Two control systems were included in each HI test. A hemagglutination
titration of the antigens involved was prepared, allowed to sit overnight, and
read after addition of the goose erythrocyte suspension the next morning. Also,
one well for each ascitic fluid used was prepared by adding one drop of the ascitic
fluid in its most concentrated form to one drop of the 0.4%, pH 9.0 bovine
albumin diluent. After likewise sitting overnight, two drops of pH 6.0 goose
erythrocyte suspension were added
to each well and the results read. Thus
variations in antigen titer and appearance of non-specific hemagglutination
were controlled.
Neutralization test technique was a varying virus, constant serum procedure,
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carried out in one- to three-dav old Swiss mice, Charles River stock (12).
Virus and ascitic fluid stocks and 0.75% phosphate buffered bovine
albumin (BAP) prepared for these experiments or withdrawn from the WHO Reference
Bank as previously described were used.
Lyophilized virus was first rehydrated with BAP to a 1:50 dilution which
was then further diluted serially in ten-fold steps from 1:50 to the level
appropriate to the particular test. Aliquots of these dilutions were then added
to equal volumes of the various ascitic fluids included in the test, one of which
was "normal" mouse ascitic fluid (i.e., ascitic fluid prepared from unimmunized
mice). These serum-virus mixtures were then incubated in a 37C water bath for
one hour. In all titrations except that denoted "Test 3", undiluted ascitic
fluid was used. In Test 3, all ascitic fluids were diluted 1:4 with BAP before
preparing the inoculum.
Each dilution was then inoculated intracerebrally (0.015 cc/mouse) into
a separate group of eight of the suckling mice. Prior to the inoculation these
mice had been taken from their original litters, randomized, and returned in
groups of eight to the mother mice. The groups were checked daily for signs
of encephalitic morbidity and for mortality, these observations recorded, and
the dead discarded. At the end of fourteen days all mice remaining alive were
discarded. All deaths occurring within twenty-four hours after inoculation were
considered artefactual and discounted.
Results of neutralization tests are reported here as log neutralization
index, calculated as described in Methods for Medical Laboratory Technicians (12)
and based on values of LDcn the dose
of virus needed to kill 50% of the mice,
as determined by the method of Reed and Muench (13) . The neutralization index
measures capacity of an immune ascitic fluid to protect the host system from
effects of the virus inoculated into it. This measure compares LD of the
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virus incubated with normal ascitic fluid and ID of the virus incubated with
50
the immune ascitic fluid. The difference between these two values is the log^g
neutralization index of the immune ascitic fluid tested. The anti-log of this
value is the neutralization index of the fluid.
Analytic Methods and Criteria of Serological Comparison of Isolates
For all three systems (CF, HI, and NT) the mathematical routine described
by Springer (19) was adopted. Due to biological variation in the materials
used virus or antigen, and ascitic fluid results of both viruses (antigens)
and both ascitic fluids were necessary for comparison of any two isolates in
any one system. In CF tests, conversion of the endpoints, using the ascitic
fluid dilution values, to their rank in order of serial, two-fold dilutions
(e.g., 1:4=1, 1:8=2, 1:16=3, etc.), allows these endpoints to be placed
on a mathematical grid, as shown.




Since, mathematically, equal values may be added to or subtracted from both
values in any one column or row without altering the essential quadrate
relationship, variations in antigen sensitivity and antibody titer may be
abnegated mathematically bv serial performance of such procedures. When
all values become equal, the antigens (and hence isolates) may be defined
as equal, or indistinguishablv similar by the test used. When only three of
the four values may be made equal, then the antigens (isolates) may be defined
as different from one another by the difference between the common value and
the odd value. This difference is stated in "number of two-fold dilutions."
This same system of comparison is applicable to HI results, and to NT
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results (substituting log neutralization indices for two-fold dilution values).
Formal application of this system was actually necessary only with the wealth of
data obtained from CF tests. The results of HI tests were so limited that inter-
isolate comparisons were made within this system merely bv scanning the result
table and performing the comparison in the mind. This was also possible with the
straightforward NT results, once the differences between homologous and hetero
logous lglr. neutralization indices had been calculated and displayed in Table 7.
The values stated there were arrived at bv subtraction of log neutralization
index of heterologous ascitic fluid from log neutralization index of homologous
ascitic fluid, as determined in the individual test (1, 2, or 3) concerned.
Homologous and heterologous values of different tests were not used inter
changeably in these calculations.
The criteria for clustering isolate viruses in the inter-isolate serological
classification here proposed are not primarily definite, absolute, and requisite
of complete similarities, but regard more importantly pattern of evident relation
ships. Each cluster proposed contains isolates closely related in the system
used, and each isolate of a cluster is more closely related to all other isolates
in that cluster than to any isolate outside it, in another cluster. However,
certain minimal indications of close relationship are considered in each sero
logical system, according to the relative inclusiveness of the system: CF, 42
two-fold dilutions difference; HI, 1 two-fold dilution difference; and NT,
difference between log neutralization indices of homologous and heterologous
10
ascitic fluids 1.0, reciprocally.
Additional Procedures and Criteria in Preparation of Adequately Active
Hemagglutinating Antigens
Several additional procedures were performed on sucrose-acetone extracted
-16-
antigens in attempts to elicit adequate hemagglutinating activity. Adequate
activity was taken to be complete or partial hemagglutination at an antigen
dilution 1:16. Such activity made HI testing possible. A successful preparation
of antigen was one manifesting such activity in one or more pH ranges at any
point in the procedures of preparation. Rare exceptions to these criteria are
noted in the reporting of results. HA titrations were carried out on aliquots
of antigen collected at various points in the procedure, as noted on Table 8.
At the completion of sucrose-acetone extraction (sa extr.), antigens were
subjected successively to sonlcation (son.), trypsinization (tryp.), and resoni
cation (reson.), in that order. Sonlcation is a method of disrupting particulate
matter by subjecting it to high intensity, high frequency sonic energy. Ten to
twenty cc of antigen were placed in a 16x160 mm glass test tube suspended in
a cooling bath of either brine, or dry ice, water, and ethyl alcohol. The
sonic energy horn attached to a Sonifier Cell Disruptor power source (Heat
Systems Co., Melville L.I., N.Y.) was inserted Into the antigen and sonication
at approximately twenty watts carried out for a two minute period, this being
followed by a one minute silence, allowing the antigen to cool. This pattern
of sonication and silence was repeated for a total of three cycles in those
antigens sonicated but not trypsinized or resonicated. In a few instances,
hydrogen gas was bubbled through the antigen prior to sonication and left layered
over it in bubbles during the cycles.
Trypsinization is a method of particle disruption depending on the lytic
action of the enzyme trypsin on chemical bonds. After four cycles of sonication
two minutes, silence two minutes, without hydrogen, the antigen was centrifuged
for five to ten minutes at 2,000 rpm, and the pellet discarded. Commercial trypsin
(Difco Laboratories) was prepared in a 512 JVM solution with borate saline,
pH 9.0. After remaining
at room temperature for five minutes, this solution
was added to an equal volume of the sonicated, centrifuged antigen, yielding
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a solution with the final trypsin concentration of 256 JC/ml. This
remained
at room temperature for fifty minutes. Then commercial soybean trypsin
inhibitor (Worthington Biochemical Corporation) was added, 128 /ml of solution.
This last solution was left for at least one hour at room temperature before
HA titration. If not titrated immediately it was stored in 1.0 cc aliquots at
-70C and allowed to be thawed only once before titration and use or discarding.
If acceptable hemagglutinating activity did not emerge after trypsinization,
the antigen was finally sonicated once more (resonicated) , without hydrogen,
for a one minute period, and re-evaluated.
Between performance of all the various procedures or tests, the antigens
were stored either at 4C or -70C, in bulk or in small ampoules. The only
controls included with these empirical attempts at development of HA activity
were those inherent in simultaneous HA titration of variously treated aliquots





Results of the homologous CF titration of hyperimmune mouse ascitic
fluids appear in Table 2. All ascitic fluids titered 1:128 except lb An 10107
and lb An 9398, which titered 1:32.
Results of heterologous CF testing of the eight isolate antigens against
their ascitic fluids appear in Table 3. One simultaneous test yielded all
the results shown. A homologous titration was coincidentally repeated, being
included as a control. Through dilution 1:1024 all antigens except Yaba 7
manifested 3+ to 4+ CF reactions with their most concentrated homologous
ascitic fluid. Yaba 7 antigen manifested such a reaction only through dilution
1:256. It was assumed that maximum antibody titers were developed by antigen
dilutions between 1:4 and 1:1024. Those ascitic fluids showing no evidence of
diminution of antibody titer peak by 1:1024 antigen dilution were assumed to
be at peak, and this value recorded.
A comparison of the eight isolates based on the information contained
in Table 3 and employing the analytical methods described on page 14 is
presented in Table 4. The apparent CF serological grouping of isolate viruses,
according to the stated criteria, is also delineated in Table 4.
This classification by CF serology includes three groups of viruses in
which all members are similar to within 1 two-fold ascitic fluid dilution of
one another. There is one exception: the separation of lb An 5077 and lb An 10599
by 2 two-fold dilutions.
However both of these viruses are still far more
closely related to one another than to any isolates outside the group.
Table 2. Homologous CF Titration of Hyperimmune Mouse Ascitic Fluid Produced and/or Used for Serological
Comparison of 8 Nigerian Simbu group Viruses
Ascitic Fluid Hyperimmune to Virus
lb An 5077 lb An 10598 lb An 10599 lb H 11003 Yaba 7 lb An 5550 lb An 10107 lb An 93981
Antigens
^
lb An 5077 V.28
lb An 10598 ^128
lb An 10599 *128
lb H 11003 $128
Yaba 7 *128
lb An 5550 *L28
lb An 10107 32
lb An 9398 32
^ouse ascitic fluid from WHO Reference Laboratory stocks: lb An 9398 (MG 48872, Source 48743)
2Antigens diluted 1:40
Table 3. Homologous and Heterologous CF Titration of 8 Nigerian Simbu group Viruses
Antigen
lb An 5077 512
lb An 10598 512
lb An 10599 128
lb An 10107 256
lb H 11003 256
Yaba 7 32
lb An 9398 64
lb An 5550 64
Antibody (Ascitic Fluid)
lb An 5077 lb An 10598 lb An 10599 lb An 10107 lb H 11003 Yaba 7 lb An 9398 lb An 5550
32 128 64 8 64
32 256 32 8 32
32 128 32 8 32






-C32 (64)* <8 (8)
32 4
<32 (64) 4
16 128 32 4 32
<4 (8) 16 128 16 32
4 32 128 32 32
8 16 32 8 128
*Values in parentheses represent titers obtained in repeat tests, and are not used creating Table 4.
Table 4. Serological Comparison of 8 Nigerian Simbu group Viruses, CF Technique
(Source of Data, Table 3)
Virus
Isolate
lb An 5077 lb An 10598 lb An 10599 lb An 10107 lb H 11003 Yaba 7 lb An 9398 lb An 5550
lb An 5077 0 1* 2 0 1 5 5 4
lb An 10598 0 1 1 1 >3 3 >3
lb An 10599 0 0 0 >4 5 5
lb An 10107 0 0 >4 5 4
lb H 11003 0 5 5 5
4Yaba 7 0 1
lb An 9398 0 4
lb An 5550 0
*Values shown are the number of two-fold dilutions difference between ascitic fluids.
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HI Tests
Results of both homologous and heterologous HI titrations of those
isolates tested are found in Table 5. Tests 1 and 2 were performed on
separate days.
These results make plain the identity, or near identity of lb An 10598
and lb An 5077, at most only 1 two-fold ascitic fluid dilution distant from one
another. lb An 10107, however, is seen to be entirely separate from both, by
HI serology, being 3 two-fold dilutions distant from lb An 10598, and 2 from
lb An 5077. Since no homologous HI reaction took place between lb An 10599
antigen and ascitic fluid, no positive control was present in comparison of this
ascitic fluid heterologouslv with lb An 10598 and lb An 5077 antigen. There
fore, no absolutely definite statement is possible about the relationship of
these two with the former. However, the other results present in Test 2
indicate that the three are probably quite similar.
Thus it appears that the virus isolates mentioned here, on the basis of
HI serology and stated criteria, should be arranged in two mutually exclusive
groups, one containing lb An 10598 and lb An 5077, and possibly lb An 10599,
the other containing lb An 10107-
Table 5. HI Comparison of Simbu group Viruses from Nigeria
Antibody (Ascitic Fluid)
lb An 5077 lb An 10598 lb An 10107 lb An 10599 lb H 11003 Yaba 7 lb An 9398 lb An 5550
Antigen Units pH
Test 1
lb An 5077 4 6.2 1:10 1:10 O2 0 0 0 0 0













0 0 0 0
lb An 5077 4
lb An 10598 4 6.0 1:20 1:20 0
lb An 10599 8 6.0 1:20 1:20 0




Results of both homologous and heterologous NT titrations are displayed as
log neutralization indices in Table 6 and the isolates compared by their use
in Table 7. Revelation by Test 1 that isolates lb An 5077 and lb An 10599
were indistinguishably similar, within the limits of experimental variation,
led to substitution of lb An 5077 for both in all subsequent tests (Tests 2
and 3). In computing data for Table 7 from that of Table 6, lgin neutrali
zation indices stated as having values greater than x were assumed to have
the value x, on the basis of qualitative trends evident in the titrations.
Lines of division shown on Table 7 delineate the apparent NT serological
grouping of the isolates tested, in light of the stated criteria.
This classification by NT serology includes five groups. The first
contains lb An 5077 and lb An 10599, indistinguishably similar viruses within
limits of the test, having ascitic fluids with reciprocal neutralization
capacities no more distant from each other than 0.2 log neutralization index.
10
The second group contains two indistinguishable virus isolates, lb An 10107
and lb H 11003, whose ascitic fluids appear the same in reciprocal neutralizing
capacities. The three remaining groups are made up of one individual virus
isolate each, none apparently closely related to any of the other isolates
tested here. These three groups are comprised of Yaba 7, lb An 9398, and
lb An 5550, respectively.
Table 6. Homologous and Heterologous Neutralization Titration of 7 Nigerian Simbu group Viruses
Ascitic Fluid Hyperimmune to Virus
lb An 507 7 lb" An 10599 lb An 10107 lb H 11003 Yaba 7 lb An 9398 lb An 5550
Virus Test
Number




lb An 10599 1 1.6
lb An 10107 1
3
0






lb An 9398 1
2 0




3.8 0.6 0.3 0.1
1.:
3.2























Table 7. Serological Comparison of 7 Nigerian Simbu group Viruses by Neutralizing Capacities
of Homologous and Heterologous Ascitic Fluids
(Source of Data, Table 6)
Ascitic Fluid Hyperimmune to Virus
lb An 5077 lb An 10599 lb An 10107 lb H 11003 Yaba 7 lb An 9398 lb An 5550
Virus
lb An 5077 0 0 3.2 3.5 4.3 4.3 3.7
lb An 10599 0.2* 0
3.5 3.3 3.1lb An 10107 3.2 0 0





Yaba 7 3.6 3.6 3.6 o
lb An 9398 3.3 3.3 3.3 2.2 0
lb An 5550 1.6 3.0 3.8 3.1 3.8 0
*Values stated represent the difference between log neutralization index of the indicated
ascitic fluid and the homologous ascitic fluid of the virus concerned.
-21-
Serological Classification Summary
A summary of the proposed inter-isolate serological classification, based
on the results of CF, HI, and NT tests presented is displayed in Graph 1, below.
Graph 1.
Serological Inter-isolate Classification
i closely related or equal by CF






| Yaba 7 lb An 9398
| lb An 5550
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Use of Sonication, Trypsinization, and Resonication for Preparation of
Hemagglutinating Antigens
Results of the additional procedures used in attempts to produce adequate
HA activity in sucrose-acetone extracted antigens of the eight isolates appear
in Table 8. Using these data, with regard to the stated criteria, successful
and unsuccessful preparations of HA antigen are listed in Table 9.
In two instances the criteria described were felt inadequate. lb An 5550
antigen, sucrose-acetone extracted 8/14/67, only showed trace hemagglutination
at dilution 1:256, pH 5.8, after extraction. This only improved to partial
hemagglutination at the same dilution and pH and to trace hemagglutination at
the same dilution in two other pH ranges after sonication. This zone phenomenon
was felt to represent unusable HA activity because of its unstable pattern, and
the antigen was consequently counted as an unsuccessful preparation. Yaba 7
antigen, sucrose-acetone extracted 8/17/67, was found to have an unstable pattern,
also, at pH 6.4, with complete hemagglutination at a 1:4 dilution, but no hemagglu
tination at dilutions greater and less than 1:4. The pattern was even more
unstable at pH 6.6, showing partial hemagglutination at dilutions 1:2, 1:128,
and 1:256, with only trace hemagglutination in between. This pattern deteriorated
after sonication. As a consequence, all of these results were counted as
unsuccessful in an otherwise also unsuccessful preparation.
In reviewing the results on Tables 8 and 9 one may observe that adequate
HA antigen was successfully prepared always for lb An 5077, never for lb An 9398,
lb H 11003, and Yaba 7, and occasionally for lb An 10598, lb An 10107, lb An 10599,
and lb An 5550.







lb An 5077 8/10/67 8/11/67
lb An 5550 8/14/67 8/15/67




















lb An 5077 6/11/68 6/14/68
lb An 10598 6/11/68 6/14/68
lb An 10107 6/11/68 6/14/68
Ih An 5550 6/13/68 6/14/68
lb An 10599 6/13/68 6/14/68
lb An 9398 6/13/68 6/14/68
Yaba 7 6/13/68 6/14/68
































































Greatest Dilution Showing Hemagglutination







































^Second of double dates indicates date of HA testing after resonication.
le 9. Successful and Unsuccessful Preparations of Hemagglutinating Antigen
of 8 Nigerian Simbu group Viruses
(Listed by antigen isolate number and date of sucrose-acetone
extraction; source of data, Table 8)
Successful Unsuccessful
lb An 5077 8/10/67
lb An 5077 6/11/68
lb An 10598 8/16/67
lb An 10107 8/28/67
lb An 10599 6/13/68
lb An 5550 6/13/68
lb An 10598 6/11/68
lb An 10107 6/11/68
lb An 10599 8/29/67
lb An 5550 8/14/67
lb An 5550 12/26/67
lb An 9398 8/25/67
lb An 9398 6/13/68
lb H 11003 8/30/67






Occasional technical problems were encountered in the course of sero
logical testing to determine the relationships of the various isolate viruses.
These appeared to be due to expected biological variations and will be mentioned
briefly.
Hyperimmune mouse ascitic fluids manifested different antibody titers
in homologous CF testing due to variations in virus virulence, degree of antigenic
stimulus present, and immunologic competance of the mice involved in their
production. Minimal variations in biological materials and technique involved
account for slight variations in results obtained occasionally in heterologous
CF titrations (as recorded parenthetically in Table 3).
Lack of several hemagglutinating antigens prevented positive control of the
corresponding ascitic fluids used in HI serology. Casals has noted that such
uncontrolled ascitic fluids are useful in HI titrations (1), but this is
obviously so only if positive reactions are obtained. Exclusively negative
reactions could be consistent with a lack of even homologous inhibitory anti
body in the fluids, as seen in the case of fluid for lb An 10599, Test 2,
Table 5. Consequently the uncontrolled sera of HI Test 1 were considered not
interpretable (Table 5) .
Serological classification of arboviruses is a rather nebulous subject
presently. Terminology is evolving
and is not always used in a standard way,
especially below serological group
level. Certainly set criteria are not
available to define serological relationships, as well.
Casals, however, has reviewed these difficulties nicely, introducing a
great deal more
order to the situation (5) . He notes the possibility of a
totally unmanageable
classification system, with individual viruses considered
separate entities
unless exactly identical. He also indicates a range of
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alternative systems, and finally describes a quite practical system comprised
of individual viruses clustered according to their close resemblance to a model,
or prototype virus, each cluster defining a type of virus or virus "species".
The inter-isolate serological classification proposed for the eight viruses
studied here is largely modeled after this last system. Criteria for the rela
tionships demonstrated by each serological system were established to be
mutually inclusive of all "species" members and exclusive of all members of
other "species". Each member of a "species" cluster was more closely related
to all the other members of its "species" than it was to any member of any
other "species".
Within the CF system three "species" were determined in this manner. The
HI system was found more exclusively definitive of "species", demonstrating
at least two distinct types entirely within one of the clusters previously
determined by CF serology. The NT system also seemed to define "species"
more exclusively than the CF system, demonstrating at least five within the
three the latter had shown. And again, as with the two HI clusters, none of
these five clusters crossed CF-determined "species" boundaries.
Such variation in classification results reflect different serological
system specificities, CF being the most inclusive, and HI and
NT the most
exclusive systems for group Simbu viruses.
Such variation also presents the
question of which system to
use in defining serological "species" clusters.
This ultimately seems to depend upon
the situation requiring "species" classi
fication, and consequently, upon
the pragmatic decision of the investigator
involved.
Ramifications of such pragmatism are manifold since the classification of
arboviruses is important
in several ways. Results of serological surveys
and diagnoses are
analyzed with regard to serological classification, and
consequently it serves
as basis for decisions made in identification, control,
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and therapy of arboviral diseases, as well as epidemiological interpretation
regarding ecology, geographical distribution, and evolution of these viruses.
Some epidemiological speculation seems germane at this point, since it
has recently been reported by Causey, Kemp, and Causey that a herd of dairy
cattle studied in Nigeria has progressively developed NT antibody to several of
the group Simbu viruses studied here (6) . That report noted that all animals
over 52 months of age had developed neutralizing antibodies for lb An 9398,
lb An 10107, lb An 5550, and lb An 5077. It is immediately evident that these
represent all three CF "species", and four of the five NT/HI "species" deter
mined in this investigation. However, Shope, et al. , have hypothesized that
Bunyamwera supergroup viruses have evolved from a single ancient predecessor
and should vary antigenically in different geographical areas or in different
cycles in the same ecosystem (17). With this hypothesis in mind it is curious
that there is now evidence of several supergroup Bunyamwera, group Simbu viruses
existing in individuals of the same cycle of one ecosystem in one geographical
area. One might hypothesize from such a curiosity that the original home of
an ancestral virus (of group Simbu, or groupings of higher or lower level) had
been found by chance, in the vicinity of which one might expect more coexistent
antigenic varieties. Or one might otherwise think that in the passage of time
viruses evolved in different milieus from one ancestor might have returned,
perhaps in cattle driven to market or in migratory birds to once more cohabit
in the same milieu.
Such speculations as these would perforce bear in mind possible lack of
significant correlation between jin
vitro serological reactions and ion vivo
immunological reactions. Repeated indication of past infection by two viruses
of the same CF "species" (lb An 10107 and lb An 5077) in an individual animal
seems serologically inappropriate, since it is reasonable to expect the infection
by the first
to provide immunologic intolerance to infection by the second.
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However, indication of past infection by four different NT/HI "species1' viruses
in one animal appears quite appropriate serologically, since it is expected that
these would produce no immunologic intolerance to one another. Thus there does
appear to be a lack of correlation between in vitro CF testing and in vivo
immunologic reactions. This must call into question the proper place of CF
technique in arbovirus evaluation, such question rendering the technique value
less in considering the hypothesis of note here.
However, there appears no such lack of correlation or question regarding
NT /HI determined virus "species". Consequentlv one might also postulate that
perhaps the serological tests or criteria used here define "species" too ex
clusively for the particular purpose of establishing the evolutionary hypothesis
presented. A more inclusive definition of species may be indicated, based on
host range and other ecological considerations instead of serology, perhaps
treating the serological clusters determined here as "sub-species" and "varieties".
This seems especially possible since the serological information reported
from dairy cattle may be evidence of past infection in incidental hosts,
rather than in hosts of the ecosystem usually maintaining the viruses in the
geographical area.
In the investigation immediately at hand, where merely a serological
inter-isolate classification was intended, it was felt sufficient in the
end to cluster the virus isolates studied into five NT /HI "species", contained
within three CF "super-species", as illustrated in Graph 2.
Scrutiny of results of the procedures employed in producing adequately
active HA antigens reveals that
successful preparation correlated uniformly
only with the individuality
of the antigens themselves. Uniform correlation
of successful preparations with other factors, such as variations in techniques
or individual procedures was impossible.
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Such observations are probably explicable on the basis of variations in
titer and/or structure of the individual antigens, and the response of their
structural components to the procedures. Some of the antigens, such as lb An 5077,
may have a great number of antigenically active hemagglutinating sites per unit
of antigen, all relatively superficially accessible for serological interaction.
Others, such as lb An 9398, lb H 11003, and Yaba 7, may be considerably less
optimally endowed, having fewer sites or less accessible arrangements of them,
or both. Physical disruption of such units by the high intensity sonic energy
of sonication, or chemical disruption of the peptide bonds within such units by
proteolytic enzyme trypsin could conceivably alter either the number or accessi
bility of such active antigenic sites. The original structure (accessibility,
complexity) and number of antigenically active sites would moderate response
to such procedures, however. Creation and augmentation or destruction and
diminution of these sites would respectively increase or decrease the overall
activity of the antigen. The results obtained with these procedures contain
numerous examples in which such alterations may have occured.
Should this simplified explanation be essentially correct, it is easily
conceivable that with further empirical experimentation, technical proficiency
will be developed and other special procedures discovered which will improve
and facilitate consistently successful preparation of hemagglutinating activity
from all the antigens studied here.
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